Accurate and Safe Fetal Monitoring, DLV-719500
In 2015, Nemo applied for an EU Horizon 2020 SME (Small and Medium Sized Enterprises) Phase 2 grant, after successfully completing an SME Phase 1 grant earlier that year. The Phase 2 grant was awarded in 2016 for the development of novel technologies to improve fetal monitoring.
With this grant, we are going to develop the next generation of fetal monitoring, based on the technology of electrophysiological monitoring. Our solution enables medical professionals to obtain more information to better assess fetal wellbeing in earlier stages of pregnancy and in labor and delivery. The long-awaited promise of fetal ECG is finally going to be delivered!